Imatinib Treatment in Primary Acute Basophilic Leukemia with FIP1L1-PDGFRα Rearrangement: A Case Report
The patient successfully achieved a complete response to treatment and remained relapse-free during an 18-month follow-up. This case underscores the importance of accurate and timely diagnosis and individualized treatment, and it provides valuable insights for managing similar cases of ABL.
Authors
- Jun Yin
- Jingxing Yi
- Daixin Huang (ORCID: https://orcid.org/0000-0001-8909-2375)
- Jiefang Li (ORCID: https://orcid.org/0000-0002-5224-8337)
- Zewen Zhang (ORCID: https://orcid.org/0000-0001-9370-8793)
- Qing-Yi Guo (ORCID: https://orcid.org/0009-0002-2284-9681)
- Lei Yu (ORCID: https://orcid.org/0000-0002-0237-8758)
- Jichao Wu (ORCID: https://orcid.org/0009-0007-1358-020X)
Institutions
- Shantou University (CN)
- Qingzhou City People's Hospital (CN)
- Second Affiliated Hospital of Shantou University Medical College (CN)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1159/000549406
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.00